Clinical studies recruiting near Tbilisi

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 2680002 · Sanofi · NCT06867094 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Israel- Georgian Medical Research Clinic Healthycore · Shanghai Henlius Biotech · NCT07160335 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Phase 3 · Aversi Clinic · Octapharma · NCT04918173 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · LTD "Israel-Georgian Medical Research Clinic "Healthycore" · UroGen Pharma Ltd. · NCT06774131 Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt
Phase N/A · Davinci Eye Center, LTD · Davinci LTD · NCT06691555 Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1 · LLC ARENSIA Exploratory Medicine · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT06980116 Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Phase 2/Phase 3 · Pineo Medical Ecosystem · Skyhawk Therapeutics, Inc. · NCT07378644 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · LTD Israeli-Georgian Medical Research Clinic Healthycore · Boehringer Ingelheim · NCT07220083 A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection
Phase 2 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT07503873 REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Phase 3 · American Hospital Tbilisi · Regeneron Pharmaceuticals · NCT07410117 Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Phase 2 · JSC Curatio · NMD Pharma A/S · NCT06414954 PRIDE III Prison Interventions and HIV Prevention Collaboration
NA · Alternative Georgia · Yale University · NCT06962033 Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Phase 3 · K Eristavi National Center of Experimental and Clinical Surg · Vega Therapeutics, Inc · NCT07115004 Volrustomig Priming Regimens Exploratory Phase II Platform Study
Phase 2 · Research Site · AstraZeneca · NCT06448754 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · ARENSIA Exploratory Medicine LLC · Boehringer Ingelheim · NCT07472517 Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
EARLY_Phase 1 · Healthycore · EnCompass Technologies, Inc. · NCT05866640 L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adu
Phase 2/Phase 3 · GEORGIA: LLC ARENSIA Exploratory Medicine · Moleculin Biotech, Inc. · NCT06788756 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment
NA · Israeli-Georgian Medical Research Clinic Healthycore · Tau-MEDICAL Co., Ltd. · NCT06877520 A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
Phase 2 · Ltd Tbilisi Central Hospital · H. Lundbeck A/S · NCT06471829 AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Phase 2 · Research Site · AstraZeneca · NCT06219941 Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Coli
Phase 3 · ARENSIA Exploratory Medicine Georgia ( Site 1104) · Merck Sharp & Dohme LLC · NCT06651281 A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Phase 3 · Petre Sarajishvili Institute of Neurology · argenx · NCT07091630 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Investigational Site Number : 2680006 · Sanofi · NCT07184931 Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients W
Phase 3 · University Hospital · BioVersys SAS · NCT07326540 A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropeni
Phase 3 · LTD "Israeli-Georgian Medical Research Clinic Healthycore" · X4 Pharmaceuticals · NCT06056297 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site GE99501 · Astellas Pharma Global Development, Inc. · NCT02960022 A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
Phase 1/Phase 2 · David Metreveli Medical Centre, Tbilisi · H. Lundbeck A/S · NCT05669950

Look up another city

Look up another condition